Kapus A, Lukàcs G L
Biochem Pharmacol. 1986 Jul 1;35(13):2119-22. doi: 10.1016/0006-2952(86)90579-4.
The clinically effective hepatoprotective flavonoid, (+)-Cyanidanol-3, prevented the Fe2+-induced functional deterioration of rat liver mitochondria. Fe2+ treatment of mitochondria resulted in increased lipid peroxidation (MDA-formation), decreased mitochondrial membrane potential, impaired Ca2+ uptake capacity and caused large amplitude swelling of mitochondria. All of the consequences of Fe2+ treatment were inhibited by (+)-Cyanidanol-3 in a concentration dependent manner. The mitochondrial protective action of the drug is comparable with its free radical scavenging property.